Eurand to Present At Deutsche Bank 2008 Small and Mid Cap Growth ...

  • email Email to a friend
  • print Print version

Did you enjoy this article?

(total 0 votes)
Try our own cheap Booking Service226 times read : Adjust font size: Decrease font Enlarge font
image

MSN MoneyCentral - AMSTERDAM, The Netherlands, Feb. 7, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies ...

Read this article...



Post your comment comment Comments (0 posted)

copyright